Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

A comparison of 2 strategies to prevent infection following pertussis exposure in vaccinated healthcare personnel.

Goins WP, Edwards KM, Vnencak-Jones CL, Rock MT, Swift M, Thayer V, Schaffner W, Talbot TR.

Clin Infect Dis. 2012 Apr;54(7):938-45. doi: 10.1093/cid/cir973. Epub 2012 Jan 11.

2.

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A; Stage III Working Group..

Pediatrics. 2001 Nov;108(5):E81.

PMID:
11694665
3.

Does tetanus-diphtheria-acellular pertussis vaccination interfere with serodiagnosis of pertussis infection?

Pawloski LC, Kirkland KB, Baughman AL, Martin MD, Talbot EA, Messonnier NE, Tondella ML.

Clin Vaccine Immunol. 2012 Jun;19(6):875-80. doi: 10.1128/CVI.05686-11. Epub 2012 Apr 25.

4.

Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis.

Langley JM, Halperin SA, Boucher FD, Smith B; Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC)..

Pediatrics. 2004 Jul;114(1):e96-101.

PMID:
15231980
5.

Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.

Wei SC, Tatti K, Cushing K, Rosen J, Brown K, Cassiday P, Clark T, Olans R, Pawloski L, Martin M, Tondella ML, Martin SW.

Clin Infect Dis. 2010 Aug 1;51(3):315-21. doi: 10.1086/653938.

PMID:
20578875
6.
7.

Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants.

Healy CM, Rench MA, Baker CJ.

Clin Infect Dis. 2013 Feb;56(4):539-44. doi: 10.1093/cid/cis923. Epub 2012 Oct 24.

PMID:
23097585
8.

Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population.

Knuf M, Zepp F, Meyer C, Grzegowski E, Wolter J, Riffelmann M, Wirsing von König CH.

Vaccine. 2006 Mar 15;24(12):2043-8. Epub 2005 Nov 28.

PMID:
16356597
9.

[Detection of Bordetella pertussis infection by culture, real-time polymerase chain reaction and serologic tests among children with prolonged cough].

Gürsel D, Aslan A, Sönmez C, Koturoğlu G, Cöplü N, Kurugöl Z, Aydemir S.

Mikrobiyol Bul. 2012 Apr;46(2):211-24. Turkish.

PMID:
22639310
10.

Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.

Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, Tiwari T, Cohn AC, Slade BA, Iskander JK, Mijalski CM, Brown KH, Murphy TV; Centers for Disease Control and Prevention.; Advisory Committee on Immunization Practices.; Healthcare Infection Control Practices Advisory Committee..

MMWR Recomm Rep. 2006 Dec 15;55(RR-17):1-37.

11.

The induction of breast milk pertussis specific antibodies following gestational tetanus-diphtheria-acellular pertussis vaccination.

Abu Raya B, Srugo I, Kessel A, Peterman M, Bader D, Peri R, Ashtamker N, Gonen R, Bamberger E.

Vaccine. 2014 Sep 29;32(43):5632-7. doi: 10.1016/j.vaccine.2014.08.006. Epub 2014 Aug 19.

PMID:
25148774
12.

Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak control.

Kirkland KB, Talbot EA, Decker MD, Edwards KM.

Clin Infect Dis. 2009 Aug 15;49(4):584-7. doi: 10.1086/603555.

PMID:
19589084
13.

Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.

Ladhani SN, Andrews NJ, Southern J, Jones CE, Amirthalingam G, Waight PA, England A, Matheson M, Bai X, Findlow H, Burbidge P, Thalasselis V, Hallis B, Goldblatt D, Borrow R, Heath PT, Miller E.

Clin Infect Dis. 2015 Dec 1;61(11):1637-44. doi: 10.1093/cid/civ695. Epub 2015 Sep 15.

PMID:
26374816
14.

Two consecutive randomized controlled pertussis booster trials in children initially vaccinated in infancy with an acellular vaccine: The first with a five-component Tdap vaccine to 5-year olds and the second with five- or monocomponent Tdap vaccines at age 14-15 years.

Carlsson RM, Gustafsson L, Hallander HO, Ljungman M, Olin P, Gothefors L, Nilsson L, Netterlid E.

Vaccine. 2015 Jul 17;33(31):3717-25. doi: 10.1016/j.vaccine.2015.05.079. Epub 2015 Jun 7.

PMID:
26057135
16.

Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activity.

Aase A, Herstad TK, Merino S, Bolstad M, Sandbu S, Bakke H, Aaberge IS.

Clin Vaccine Immunol. 2011 Aug;18(8):1269-74. doi: 10.1128/CVI.05067-11. Epub 2011 Jun 15.

17.

Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.

America Academy of Pediatrics Commitee on Infectious Diseases..

Pediatrics. 2006 Mar;117(3):965-78. Epub 2005 Dec 28.

PMID:
16382131
18.

Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.

Bechini A, Tiscione E, Boccalini S, Levi M, Bonanni P.

Vaccine. 2012 Jul 27;30(35):5179-90. doi: 10.1016/j.vaccine.2012.06.005. Epub 2012 Jun 15. Review.

PMID:
22709953
19.

Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.

Zepp F, Habermehl P, Knuf M, Mannhardt-Laakman W, Howe B, Friedland LR.

Vaccine. 2007 Jul 20;25(29):5248-52. Epub 2007 Jun 4.

PMID:
17583395
20.

Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.

Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR; Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov..

Pediatrics. 2005 Aug;116(2):e285-94.

PMID:
16061582

Supplemental Content

Support Center